Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US62857J2015
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG002B0JJV6
MYO
Myomo, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Devices · THEMEFOLIO: $HLTH
NAME
Myomo, Inc.
ISIN
US62857J2015
TICKER
MYO
MIC
XASE
REUTERS
MYO.N
BLOOMBERG
MYO US
Di., 03.11.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the 17th Annual Craig Hallum Alpha Select Conference being held Tuesday, November 17, 2026, at the Sherat...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 02.11.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after the mar...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 12.10.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Mary-Katherine (“Katie”) McClure as Chief Commercial Officer effective October 12, 2026, succeeding Micah M...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Di., 01.09.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 at the Lotte...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 05.08.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2026. “I am pleased to report that the evolution of our...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 29.07.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026. Management will...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. Pr...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 14.05.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in two upcoming investor conferences. On May 20, Myomo’s President and Chief Executive Officer Paul Gudon...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 13.05.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2026. “Earlier this year we established four success pillars for 2026,...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 04.05.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace, announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock Care will offer the MyoPro through its clinics across the country, helping individuals with upper extremity impairment caused by...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Fr., 01.05.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026. Management will hol...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 20.04.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience. The Myomo Mobile App is designe...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 16.04.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William “Will” Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of stoc...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025. “We delivered 2025 revenue at the midpoint of our up...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts,...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Manage...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 10.11.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025. “Third quarter revenues were at the high end of our...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 03.11.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025. Management will hold a confe...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Di., 02.09.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. W...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 18.06.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth revie...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 07.05.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025. Financial and operating highlights for the first quarter of 2025...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 01.05.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place a...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 30.04.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025. The Company will host a conf...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 30.04.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, today announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line. Designed to enhance the user experience, the MyoPro 2x intro...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 10.04.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II direc...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 31.03.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and David Henry, chief financial officer, will present at the 24th An...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 10.03.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2024. Financial and operating highlights for the fourth qua...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mo., 03.03.2025       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2024 on March 10, 2025. The Company...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 05.12.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has priced an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share. Myomo...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 04.12.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with the offering, Myomo also ex...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 06.11.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and nine months ended September 30, 2024. Financial and operating highlights for the third qu...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 31.10.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces it has entered into the first contracts that will allow MyoPro to be provided to patients covered by private insurance on an in-netw...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 30.10.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2024 on November 6, 2024. The Company will ho...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Mi., 09.10.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will participate in a “Fir...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 12.09.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Pros...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink
Do., 05.09.2024       Myomo
US62857J2015

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be participating in two investor conferences during the month of September. Paul Gudonis, chairman and...
Zur Nachricht
Myomo
Charts & Research Termsheets Terminal
Permalink